Menu
What we do
Portfolio
News
Who we are
About
Team
Contact
Newsletter Sign Up
Logins
LP Login
We are investing in the
future of healthcare, see
our most recent news.
9.13.22
Upward Health Announces Growth Equity Financing Led by Heritage Group
9.13.22
Upward Health Announces Growth Equity Financing Led by Heritage Group
Filter by:
Blog
News
News
December 4, 2023
Alto Neuroscience Announces Positive Results from Phase 2 Study of ALTO-300 in Major Depressive Disorder
December 4, 2023
Alto Neuroscience Announces Positive Results from Phase 2 Study of ALTO-300 in Major Depressive Disorder
News
November 21, 2023
Alto Neuroscience Closes $45 Million in Oversubscribed Series C Financing
November 21, 2023
Alto Neuroscience Closes $45 Million in Oversubscribed Series C Financing
News
November 17, 2023
FORE Biotherapeutics Announces Oral Presentation at SNO 2023 Reporting Updated Phase 1/2a Results for Plixorafenib in BRAF V600 Advanced Solid Tumors, Including Novel Data for Patients with BRAF V600 Primary CNS Tumors
November 17, 2023
FORE Biotherapeutics Announces Oral Presentation at SNO 2023 Reporting Updated Phase 1/2a Results for Plixorafenib in BRAF V600 Advanced Solid Tumors, Including Novel Data for Patients with BRAF V600 Primary CNS Tumors
News
November 17, 2023
ChromaCode Lung Cancer Assay Shows Advantages in New Data at AMP as Company Eyes Next Applications
November 17, 2023
ChromaCode Lung Cancer Assay Shows Advantages in New Data at AMP as Company Eyes Next Applications
News
November 15, 2023
Neuspera Medical, Inc. Announces Milestone Completion of 100th Implant in Its SANS-UUI Phase II Clinical Trial
November 15, 2023
Neuspera Medical, Inc. Announces Milestone Completion of 100th Implant in Its SANS-UUI Phase II Clinical Trial
News
November 2, 2023
SubjectWell Acquires PatientCentra
November 2, 2023
SubjectWell Acquires PatientCentra
News
October 9, 2023
DELFI Diagnostics Launches FirstLook Lung, an Accessible, Accurate New Way to Enhance Lung Cancer Screening Through a Routine Blood Test
October 9, 2023
DELFI Diagnostics Launches FirstLook Lung, an Accessible, Accurate New Way to Enhance Lung Cancer Screening Through a Routine Blood Test
News
October 2, 2023
‘Build A Company To Be Bought, Not Sold,' 'Match The Asset To The Capital,' And Other Advice From VC Experts
October 2, 2023
‘Build A Company To Be Bought, Not Sold,' 'Match The Asset To The Capital,' And Other Advice From VC Experts
News
September 29, 2023
Experts in Motion: The State of MedTech Funding
September 29, 2023
Experts in Motion: The State of MedTech Funding
News
September 26, 2023
Alto Neuroscience Announces Positive Results from Phase 2 Study of ALTO-100 in Post-Traumatic Stress Disorder
September 26, 2023
Alto Neuroscience Announces Positive Results from Phase 2 Study of ALTO-100 in Post-Traumatic Stress Disorder
News
September 11, 2023
Phase 2 Data Demonstrate Potential of Vergent Biosciences’ Tumor-Targeted Fluorescent Imaging Agent to Improve Success of Lung Cancer Surgeries
September 11, 2023
Phase 2 Data Demonstrate Potential of Vergent Biosciences’ Tumor-Targeted Fluorescent Imaging Agent to Improve Success of Lung Cancer Surgeries
News
September 5, 2023
David Kereiakes, Managing Partner at Windham Venture Partners, on Becker's Healthcare Podcast
September 5, 2023
David Kereiakes, Managing Partner at Windham Venture Partners, on Becker's Healthcare Podcast
News
September 5, 2023
Adam Fine, Founder & Managing Partner at Windham Venture Partners, on Becker's Healthcare Podcast
September 5, 2023
Adam Fine, Founder & Managing Partner at Windham Venture Partners, on Becker's Healthcare Podcast
News
August 24, 2023
FORE Biotherapeutics Announces $75M in Series D Financing and CEO Transition
August 24, 2023
FORE Biotherapeutics Announces $75M in Series D Financing and CEO Transition
News
August 15, 2023
Upward Health Ranks No. 7 on the 2023 Inc. 5000
August 15, 2023
Upward Health Ranks No. 7 on the 2023 Inc. 5000
News
June 21, 2023
Windham Venture Partners Hires Successful Healthcare Investor, David Kereiakes, And Expands Presence in the Midwest
June 21, 2023
Windham Venture Partners Hires Successful Healthcare Investor, David Kereiakes, And Expands Presence in the Midwest
News
June 7, 2023
ChromaCode Announces Strategic Investment to Advance Development and Application of HDPCR Platform Technology for Use in Oncology Genomics
June 7, 2023
ChromaCode Announces Strategic Investment to Advance Development and Application of HDPCR Platform Technology for Use in Oncology Genomics
News
April 27, 2023
ChromaCode Announces Partnership with MedGenome to Bring HDPCR-based Diagnostics to India and the Middle East
April 27, 2023
ChromaCode Announces Partnership with MedGenome to Bring HDPCR-based Diagnostics to India and the Middle East
News
April 18, 2023
NEUSPERA MEDICAL ANNOUNCES FDA CLEARANCE OF ITS SYSTEM FOR PERIPHERAL NERVE STIMULATION
April 18, 2023
NEUSPERA MEDICAL ANNOUNCES FDA CLEARANCE OF ITS SYSTEM FOR PERIPHERAL NERVE STIMULATION
News
April 18, 2023
DELFI Diagnostics Presents Additional Promising Proof-of-Concept Data on its Monitoring Program at AACR 2023
April 18, 2023
DELFI Diagnostics Presents Additional Promising Proof-of-Concept Data on its Monitoring Program at AACR 2023
News
March 15, 2023
Clever Care announces Series C Fundraising: Adds New Board Member
March 15, 2023
Clever Care announces Series C Fundraising: Adds New Board Member
News
January 30, 2023
Alto Neuroscience Announces $60 Million in Additional Financing
January 30, 2023
Alto Neuroscience Announces $60 Million in Additional Financing
News
January 10, 2023
Alto Neuroscience Announces Positive Results for ALTO-100 in Phase 2 Study Supporting Advancement of First-in-Class Mechanism for Treating Depression
January 10, 2023
Alto Neuroscience Announces Positive Results for ALTO-100 in Phase 2 Study Supporting Advancement of First-in-Class Mechanism for Treating Depression
News
December 14, 2022
Alto Neuroscience Announces Positive Data from Phase 1 Study Evaluating Brain Effects of Novel Drug Combinations
December 14, 2022
Alto Neuroscience Announces Positive Data from Phase 1 Study Evaluating Brain Effects of Novel Drug Combinations
News
December 8, 2022
Alto Neuroscience Presents New Data Leveraging EEG and Machine Learning to Predict Individual Response to Antidepressants at the 61st Annual Meeting of the American College of Neuropsychopharmacology
December 8, 2022
Alto Neuroscience Presents New Data Leveraging EEG and Machine Learning to Predict Individual Response to Antidepressants at the 61st Annual Meeting of the American College of Neuropsychopharmacology
News
November 29, 2022
Vergent Bioscience Awarded National Cancer Institute Phase 2 Grant to Advance Clinical Development of VGT-309 in Lung Cancer
November 29, 2022
Vergent Bioscience Awarded National Cancer Institute Phase 2 Grant to Advance Clinical Development of VGT-309 in Lung Cancer
News
November 18, 2022
Positive Liver Cancer Detection Data Published in Cancer Discovery Shows Further Promise of Delfi's AI Liquid Biopsy Platform
November 18, 2022
Positive Liver Cancer Detection Data Published in Cancer Discovery Shows Further Promise of Delfi's AI Liquid Biopsy Platform
News
October 31, 2022
Valera Health Announces $45 Million Growth Equity Financing to Increase Access to Evidence-based Mental Health Services for High Acuity Patients
October 31, 2022
Valera Health Announces $45 Million Growth Equity Financing to Increase Access to Evidence-based Mental Health Services for High Acuity Patients
News
October 25, 2022
Alto Neuroscience Announces $35 Million Series B Financing
October 25, 2022
Alto Neuroscience Announces $35 Million Series B Financing
News
October 20, 2022
SubjectWell Raises $35 Million to Expand Patient Access to New Treatment Options
October 20, 2022
SubjectWell Raises $35 Million to Expand Patient Access to New Treatment Options
Blog
October 4, 2022
The Dye that Binds: Advances in Tumor Visualization Now Help Surgeons See Cancer in Real-Time
October 4, 2022
The Dye that Binds: Advances in Tumor Visualization Now Help Surgeons See Cancer in Real-Time
News
October 4, 2022
Vergent Bioscience Secures $21.5 Million Series B Financing to Advance Clinical Development of Tumor-Targeted Fluorescent Imaging Agent VGT-309
October 4, 2022
Vergent Bioscience Secures $21.5 Million Series B Financing to Advance Clinical Development of Tumor-Targeted Fluorescent Imaging Agent VGT-309
News
September 12, 2022
Delfi Diagnostics Selected as the Liquid Biopsy Partner for 4-IN-THE-LUNG-RUN: A Large-Scale European Lung Cancer Screening Study
September 12, 2022
Delfi Diagnostics Selected as the Liquid Biopsy Partner for 4-IN-THE-LUNG-RUN: A Large-Scale European Lung Cancer Screening Study
News
August 23, 2022
Upward Health Awarded ACO REACH Model Contract by CMS
August 23, 2022
Upward Health Awarded ACO REACH Model Contract by CMS
News
July 25, 2022
Valera Health and Horizon Healthcare Services Collaborate to Increase Access to Mental Health Care in New Jersey
July 25, 2022
Valera Health and Horizon Healthcare Services Collaborate to Increase Access to Mental Health Care in New Jersey
News
July 18, 2022
Delfi Diagnostics Announces $225 Million Series B Financing to Develop Globally Accessible Portfolio of Liquid Biopsy Tests
July 18, 2022
Delfi Diagnostics Announces $225 Million Series B Financing to Develop Globally Accessible Portfolio of Liquid Biopsy Tests
News
June 14, 2022
Neuspera Medical® Announces Second Phase of SANS-UUI IDE Clinical Trial with the Nuvella™ System
June 14, 2022
Neuspera Medical® Announces Second Phase of SANS-UUI IDE Clinical Trial with the Nuvella™ System
News
May 9, 2022
CVRx® Receives MR-Conditional Labeling Approval for its Barostim™ Heart Failure System
May 9, 2022
CVRx® Receives MR-Conditional Labeling Approval for its Barostim™ Heart Failure System
News
May 9, 2022
Delfi Diagnostics Initiates 15,000-Patient Prospective Lung Cancer Screening Trial
May 9, 2022
Delfi Diagnostics Initiates 15,000-Patient Prospective Lung Cancer Screening Trial
News
May 5, 2022
Revelle Aesthetics Unveils New Minimally Invasive Procedure for Cellulite Reduction…
May 5, 2022
Revelle Aesthetics Unveils New Minimally Invasive Procedure for Cellulite Reduction…
News
March 29, 2022
Willow® Expands Product Suite and Unveils Willow Go™, Its Fully In-Bra Wearable Breast Pump for Only $329
March 29, 2022
Willow® Expands Product Suite and Unveils Willow Go™, Its Fully In-Bra Wearable Breast Pump for Only $329
News
January 25, 2022
200th Treatment Milestone for AIRFLOW-3 COPD Trial
January 25, 2022
200th Treatment Milestone for AIRFLOW-3 COPD Trial
News
December 23, 2021
Labcorp Strengthens Oncology Leadership Position With the Addition of Personal Genome Diagnostics, a Provider of Comprehensive Liquid Biopsy and Tissue-Based Genomic Products and Services
December 23, 2021
Labcorp Strengthens Oncology Leadership Position With the Addition of Personal Genome Diagnostics, a Provider of Comprehensive Liquid Biopsy and Tissue-Based Genomic Products and Services
News
December 16, 2021
Cerebral and Alto Neuroscience Enter into Strategic Collaboration to Launch First-Ever Decentralized Study in Precision Psychiatry
December 16, 2021
Cerebral and Alto Neuroscience Enter into Strategic Collaboration to Launch First-Ever Decentralized Study in Precision Psychiatry
News
November 4, 2021
Valera Health Secures $15M Led by Windham Venture Partners to Expand the Company's Mental Health Clinical Services Across the U.S.
November 4, 2021
Valera Health Secures $15M Led by Windham Venture Partners to Expand the Company's Mental Health Clinical Services Across the U.S.
News
October 14, 2021
Alto Neuroscience Emerges with Largest Clinical-Stage Precision Psychiatry Pipeline and $40 Million in Financing
October 14, 2021
Alto Neuroscience Emerges with Largest Clinical-Stage Precision Psychiatry Pipeline and $40 Million in Financing
News
October 7, 2021
Doug Schenkel Joins Delfi Diagnostics as Chief Financial Officer
October 7, 2021
Doug Schenkel Joins Delfi Diagnostics as Chief Financial Officer
News
September 22, 2021
Clever Care Health Plan Raises Over $71 Million in Series B Funding to Accelerate Growth of its Medicare Advantage HMO Plan
September 22, 2021
Clever Care Health Plan Raises Over $71 Million in Series B Funding to Accelerate Growth of its Medicare Advantage HMO Plan
News
September 17, 2021
CVRx Added to Russell 2000® and 3000® Indexes
September 17, 2021
CVRx Added to Russell 2000® and 3000® Indexes
News
August 11, 2021
Nuvaira Announces AIRFLOW-3 COPD Pivotal Trial Milestone
August 11, 2021
Nuvaira Announces AIRFLOW-3 COPD Pivotal Trial Milestone
News
July 20, 2021
Neuspera Medical Announces Close of a $65M Series C Equity Financing
July 20, 2021
Neuspera Medical Announces Close of a $65M Series C Equity Financing
News
June 29, 2021
CVRx, Inc. Announces Upsized Pricing of Initial Public Offering
June 29, 2021
CVRx, Inc. Announces Upsized Pricing of Initial Public Offering
News
June 15, 2021
Personal Genome Diagnostics Enters Collaborative Partnership with Clinical Molecular Diagnostics Laboratory of Major University Health System
June 15, 2021
Personal Genome Diagnostics Enters Collaborative Partnership with Clinical Molecular Diagnostics Laboratory of Major University Health System
News
June 10, 2021
Upward Health Announces Contract with Clover Health to Serve Patients In Four States Under New Direct Contracting Initiative
June 10, 2021
Upward Health Announces Contract with Clover Health to Serve Patients In Four States Under New Direct Contracting Initiative
News
April 21, 2021
FemTech Leader Willow® Adds Diverse Set Of Investors In Extended Series C Round
April 21, 2021
FemTech Leader Willow® Adds Diverse Set Of Investors In Extended Series C Round
News
March 31, 2021
Delfi Diagnostics Begins Enrollment for Prospective Lung Cancer Screening Trial ahead of Planned Commercial Test
March 31, 2021
Delfi Diagnostics Begins Enrollment for Prospective Lung Cancer Screening Trial ahead of Planned Commercial Test
News
March 16, 2021
ChromaCode Selected as a Winner of $6M XPRIZE Rapid COVID Testing Competition
March 16, 2021
ChromaCode Selected as a Winner of $6M XPRIZE Rapid COVID Testing Competition
News
March 4, 2021
Growing Medication Management Optimization Company, Cureatr, Names New Executive Leadership
March 4, 2021
Growing Medication Management Optimization Company, Cureatr, Names New Executive Leadership
News
March 4, 2021
ControlRad® Announces FDA Clearance for ControlRad Select
March 4, 2021
ControlRad® Announces FDA Clearance for ControlRad Select
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.png)
.jpg)
.jpg)
.jpg)
.jpg)
